These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27102582)

  • 21. Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.
    Mamic P; Heidenreich PA; Hedlin H; Tennakoon L; Staudenmayer KL
    J Card Fail; 2016 Nov; 22(11):891-900. PubMed ID: 27317844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Among inpatients, ischemic bowel disease predisposes to Clostridium difficile infection with concomitant higher mortality and worse outcomes.
    Adejumo AC; Akanbi O; Pani L
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):109-115. PubMed ID: 30513074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.
    Psoinos CM; Collins CE; Ayturk MD; Anderson FA; Santry HP
    World J Surg; 2018 Jan; 42(1):246-253. PubMed ID: 28744593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
    Lambert PJ; Dyck M; Thompson LH; Hammond GW
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals.
    Pechal A; Lin K; Allen S; Reveles K
    BMC Infect Dis; 2016 Nov; 16(1):682. PubMed ID: 27855653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent epidemiology of Clostridium difficile infection in Japan].
    Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2015 Dec; 68(6):345-58. PubMed ID: 27004398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Robin C; Héquette-Ruz R; Guery B; Boyle E; Herbaux C; Galperine T
    Med Mal Infect; 2017 Dec; 47(8):532-539. PubMed ID: 28823390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
    Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
    BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital-acquired Clostridium difficile infection: an institutional costing analysis.
    Choi KB; Suh KN; Muldoon KA; Roth VR; Forster AJ
    J Hosp Infect; 2019 Jun; 102(2):141-147. PubMed ID: 30690051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of Clostridioides difficile infections among young and middle-aged adults: Veterans Health Administration.
    Russo EM; Kuntz J; Yu H; Smith J; Hauser RG; Halchenko Y; Young-Xu Y
    Infect Control Hosp Epidemiol; 2019 Sep; 40(9):997-1005. PubMed ID: 31322101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals.
    Delgado A; Reveles IA; Cabello FT; Reveles KR
    BMC Infect Dis; 2017 Jun; 17(1):448. PubMed ID: 28645266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of Clostridium difficile infection: understanding the healthcare burden.
    Bouza E
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():5-12. PubMed ID: 23121549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting.
    Kuntz JL; Johnson ES; Raebel MA; Petrik AF; Yang X; Thorp ML; Spindel SJ; Neil N; Smith DH
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):1031-8. PubMed ID: 22961023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
    Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
    J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.